PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME

摘要

601306 Disclosed is a pharmaceutical composition containing at least one FGF-21 (fibroblast growth factor 21) compound according to SEQ ID NO: 2 and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist. >2GHPIPDSSPLLQFGGQVRQRYLYTDDAQQTEAHLEIREDGTVGGAADQSPESLLQLKALKPGVIQILGVKTSRFLCQRPDGALYGSLHFDPEACSFRELLLEDGYNVYQSEAHGLPLHLPGNKSPHRDPAPRGPARFLPLPGLPPAPPEPPGILAPQPPDVGSSDPLSMVGPSQGRSPSYAS